France· FR:67658315
DIVALCOTE 500 mg, comprimé gastro-résistant
A medicinal product containing divalproate de sodium, registered in France by VIATRIS SANTE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- DIVALPROATE DE SODIUM
- Manufacturer
- VIATRIS SANTE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip13340093019557490 plaquette(s) aluminium de 1 comprimé(s)EUR 22.86
- cip133400930212578plaquette(s) aluminium de 90 comprimé(s)EUR 22.86
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Divalproate de sodium in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBelvo 500mg gastro-resistant tabletsConsilient Health Ltd
- NetherlandsDepakine Enteric 500 mg, maagsapresistente tablettenBModesto B.V.
- CanadaAPO-DIVALPROEXAPOTEX INC
- SpainDEPAKINE 500 mg COMPRIMIDOS GASTRORRESISTENTESSanofi Aventis S.A.
- United StatesValproicActavis Pharma, Inc.
- SwitzerlandConvulex
- PolandConvulexInPharm Sp. z o.o.
- BelgiumConvulex 300 mgG.L. Pharma
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Convulex
- Bulgaria · Convulex, Конвулекс
- Czechia · Convulex
- Germany · Convulex
- Estonia · Convulex
- United Kingdom (Northern Ireland) · Convulex
- Hungary · Convulex
- Lithuania · Convulex
- Latvia · Convulex
- Poland · Convulex, Convulex 150
- Portugal · Ácido Valpróico Generis
- Romania · Convulex
- Slovakia · Convulex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/043e1d06-a669-4ac6-a03f-20efed5e16d2 GET /v1/drugs/043e1d06-a669-4ac6-a03f-20efed5e16d2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67658315",
"date_amm": "2021-01-28",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "DIVALPROATE DE SODIUM",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé gastro-résistant(e)",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about divalproate de sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.